• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors




Julius L. Chen, PhD

Latest:

Prices for Physician Services in Medicare Advantage Versus Traditional Medicare

For a set of common physician services, employer-sponsored Medicare Advantage plans are found to pay prices that are similar to traditional Medicare rates.




Richard Feifer, MD, MPH

Latest:

Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce Costs

Successful patient engagement in a nationally available, remotely delivered behavioral health intervention can significantly improve medical outcomes and lower healthcare costs.



Phyllis Torda, MA

Latest:

Measuring Quality in the Early Years of Health Insurance Exchanges

This article recommends quality measures for exchange health plans and strategies to increase the availability of quality results for public reporting.


William B. Vogt, PhD

Latest:

Geographic Variation in Surgical Outcomes and Cost Between the United States and Japan

Compared with Japan, the United States has substantially less geographic variation in surgical outcomes, but it has higher variation in cost.





Linda Radler, MBA

Latest:

Clinical Outcomes and Healthcare Use Associated With Optimal ESRD Starts

Optimal end-stage renal disease (ESRD) starts were associated with lower 12-month morbidity, mortality, and inpatient and outpatient utilization in an integrated healthcare delivery system.





Brigham R. Frandsen, PhD

Latest:

Care Fragmentation, Quality, and Costs Among Chronically Ill Patients

Increased care fragmentation among chronically ill, commercially insured patients is associated with higher costs and lower quality of care.


Kate lyn Milavsky, BS

Latest:

Pilot-Testing a New Program for Providing Personalized and Patient-Centered Preventive Care

Program that enhances personalized and patient-centered preventive care at a busy inner-city primary care clinic may be associated with improved health outcomes.



Amanda Wilson, MD

Latest:

Implementing an Oncology Precision Medicine Clinic in a Large Community Health System

Precision medicine is increasingly being utilized in oncology. Aurora Health Care has implemented Syapse software to integrate molecular data into the electronic health record to accommodate precision medicine findings.


Heiner K. Berthold, MD, PhD

Latest:

Disease Management Programs in Type 2 Diabetes: Quality of Care

Disease management programs for diabetes can improve some processes of care, but they do not improve intermediate outcomes beyond doubt.




Michael S. Klinkman, MD, MS

Latest:

Barriers and Facilitators to Managing Social Care in the Digital Era Among Michigan Health Centers

There is widespread interest in understanding the role of health care in meeting social needs. This study examines community-wide activities, resources, and information technology used to manage social care.



Michael Eaddy, PharmD, PhD

Latest:

Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMIT

This cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.


Annemarie V. Wouters, PhD

Latest:

Synchronization of Coverage, Benefits, and Payment to Drive Innovation

Implementation of payment reform, without a corresponding change to coverage, benefit, and other payment requirements, creates conflicting incentives that may nullify the intended aim of payment reform: to improve health outcomes, while saving costs.



R. Brett McQueen, PhD

Latest:

Comparative Effectiveness of Early Natalizumab Treatment in JC Virus-Negative Relapsing-Remitting Multiple Sclerosis

We estimated the long-term risks and benefits of disease modifying therapies. Benefits were favored by natalizumab with minimal increased risks in the negative anti-JC virus population.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.